Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Biodefense Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global biodefense market reached a value of US$ 12.7 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Biodefense can be defined as the activity of preparing for, responding to and countering the acts of bioterrorism. A bioterrorism attack involves the deliberate release of bacteria, viruses and other pathogens that can cause chronic illnesses to humans, animals, agriculture and the environment. Biodefense involves various medical measures that are undertaken to protect individuals against biological threats, such as administering vaccinations and medicinal drugs, along with conducting research and various public health procedures. Biodefense products are commonly effective against anthrax, smallpox, botulism, radiation/nuclear disasters and other such catastrophes.

The growing threat of terrorism, coupled with continually rising tension between nations across the globe, is one of the key factors driving the growth of the market. Furthermore, the increasing defense expenditure by the governments of several nations to improve both internal and external security is also providing a boost to the market growth. In line with this, there is widespread adoption of innovative technologies, such as gene chips, for the detection of pathogens in the fields of nanotechnology, forensics and biodefense-related drug development. Additionally, government agencies are recognizing various chemical, biological, nuclear and radiological threats and are developing medical countermeasures to minimize the adverse effects of these attacks. Apart from this, there is an increasing awareness regarding synthetic biology for improving agricultural yields, which is also creating a positive impact on the market growth. Apart from these, due to the recent COVID-19 pandemic, there has been an increasing demand for medical measures and threat detection procedures, which is also providing a boost to the market growth. Other factors, including extensive research and development (R&D) in the field of biotechnology, along with the availability of advanced biothreat detection devices, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biodefense market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on vaccine type, biothreat detection device and end-user.

Breakup by Vaccine Type:

  • Anthrax
  • Smallpox
  • Botulism
  • Others
     

Breakup by Biothreat Detection Device:

  • Samplers
  • Detectors/Triggering Devices
  • Identifiers
  • Assays
  • Others
     

Breakup by End-User:

  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa


Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Achaogen Inc., Alnylam Pharmaceuticals Inc., Altimmune Inc. (PharmAthene Inc.), Bavarian Nordic A/S, Cleveland BioLabs Inc., Dynavax Technologies Corporation, Dynport Vaccine Company LLC (General Dynamics Corporation), Elusys Therapeutics Inc., Emergent Biosolutions Inc., Ichor Medical Systems Inc., Ology Bioservices Inc., SIGA Technologies, Inc., etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Vaccine Type, Biothreat Detection Device, End-User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Achaogen Inc., Alnylam Pharmaceuticals Inc., Altimmune Inc. (PharmAthene Inc.), Bavarian Nordic A/S, Cleveland BioLabs Inc., Dynavax Technologies Corporation, Dynport Vaccine Company LLC (General Dynamics Corporation), Elusys Therapeutics Inc., Emergent Biosolutions Inc., Ichor Medical Systems Inc., Ology Bioservices Inc. and SIGA Technologies, Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Biodefense Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Vaccine Type
    6.1    Anthrax
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Smallpox
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Botulism
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Biothreat Detection Device
    7.1    Samplers
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Detectors/Triggering Devices
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Identifiers
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Assays
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by End-User
    8.1    Hospitals and Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Ambulatory Care Centers
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Indicators
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Achaogen Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
           14.3.1.3 Financials
        14.3.2    Alnylam Pharmaceuticals Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Altimmune, Inc. (PharmAthene Inc.)
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
           14.3.3.3 Financials
        14.3.4    Bavarian Nordic A/S
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 Financials
        14.3.5    Cleveland BioLabs Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
        14.3.6    Dynavax Technologies Corporation
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio 
           15.3.6.3 Financials
        14.3.7    Dynport Vaccine Company LLC (General Dynamics Corporation)
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio 
        14.3.8    Elusys Therapeutics Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Emergent Biosolutions Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio 
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        14.3.10    Ichor Medical System Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio 
        14.3.11    Ology Bioservices Inc.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
        14.3.12    SIGA Technologies Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio 
           15.3.12.3 Financials

List of Figures

Figure 1: Global: Biodefense Market: Major Drivers and Challenges
Figure 2: Global: Biodefense Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Biodefense Market: Breakup by Vaccine Type (in %), 2020
Figure 4: Global: Biodefense Market: Breakup by Biothreat Detection Device (in %), 2020
Figure 5: Global: Biodefense Market: Breakup by End-User (in %), 2020
Figure 6: Global: Biodefense Market: Breakup by Region (in %), 2020
Figure 7: Global: Biodefense Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 8: Global: Biodefense (Anthrax) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Biodefense (Anthrax) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Biodefense (Smallpox) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Biodefense (Smallpox) Market Forecast: Sales Value (in Million US$), 2021-2026 
Figure 12: Global: Biodefense (Botulism) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Biodefense (Botulism) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Biodefense (Other Vaccine Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Biodefense (Other Vaccine Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Biodefense (Samplers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Biodefense (Samplers) Market Forecast: Sales Value (in Million US$), 2021-2026 
Figure 18: Global: Biodefense (Detectors/Triggering Devices) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Biodefense (Detectors/Triggering Devices) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Biodefense (Identifiers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Biodefense (Identifiers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Biodefense (Assays) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Biodefense (Assays) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Biodefense (Other Devices) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Biodefense (Other Devices) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Biodefense (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Biodefense (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Biodefense (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Biodefense (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Biodefense (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Biodefense (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: North America: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: North America: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: United States: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: United States: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Canada: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Canada: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Asia Pacific: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Asia Pacific: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: China: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: China: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Japan: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Japan: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: India: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: India: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: South Korea: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: South Korea: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Australia: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Australia: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Indonesia: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Indonesia: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Others: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Others: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Europe: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Europe: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Germany: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Germany: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: France: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: France: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: United Kingdom: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: United Kingdom: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Italy: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Italy: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Spain: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Spain: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Russia: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Russia: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Others: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Others: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Latin America: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Latin America: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Brazil: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Brazil: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Mexico: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Mexico: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Others: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Others: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Middle East and Africa: Biodefense Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Middle East and Africa: Biodefense Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Global: Biodefense Industry: SWOT Analysis
Figure 81: Global: Biodefense Industry: Value Chain Analysis
Figure 82: Global: Biodefense Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Biodefense Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Biodefense Market Forecast: Breakup by Vaccine Type (in Million US$), 2021-2026
Table 3: Global: Biodefense Market Forecast: Breakup by Biothreat Detection Device (in Million US$), 2021-2026
Table 4: Global: Biodefense Market Forecast: Breakup by End-User (in Million US$), 2021-2026
Table 5: Global: Biodefense Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Biodefense Market: Competitive Structure
Table 7: Global: Biodefense Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Question Answered in this Report

We expect the global biodefense market to exhibit a CAGR of around 6% during 2021-2026.

The growing number of terrorist attacks, along with rising cross-border conflicts, are some of the key factors driving the global biodefense market.

Sudden outbreak of the COVID-19 pandemic has positively influenced the demand for medical measures and threat detection procedures, such as biodefense.

Based on the vaccine type, the global biodefense market has been bifurcated into anthrax, smallpox, botulism, and others. Currently, anthrax holds the majority of the total market share.

Based on the end-user, the global biodefense market can be segmented into hospitals and clinics, ambulatory care centers, and others. Among these, hospitals and clinics exhibit a clear dominance in the market.

On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America dominates the global market.

Some of the major players in the global biodefense market include Achaogen Inc., Alnylam Pharmaceuticals Inc., Altimmune Inc. (PharmAthene Inc.), Bavarian Nordic A/S, Cleveland BioLabs Inc., Dynavax Technologies Corporation, Dynport Vaccine Company LLC (General Dynamics Corporation), Elusys Therapeutics Inc., Emergent Biosolutions Inc., Ichor Medical Systems Inc., Ology Bioservices Inc., SIGA Technologies, Inc., etc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links